Literature DB >> 9748620

Region- and cell-type-specific pattern of tau phosphorylation in dog brain.

J Wegiel1, H M Wisniewski, Z Sołtysiak.   

Abstract

A study of brains of 16 dogs from one to 19 years of age showed a structure- and cell-type- specific pattern of tau protein phosphorylation at mAb Tau-1 site and the absence of phosphorylation at the mAb AT8 site. Strong immunolabeling with mAb Tau-1 of the mossy fibers and perikarya of neurons in sectors CA3 and CA4 of the cornu Ammonis, less intensive staining in the cytoplasm in neocortical and subcortical neurons, and selective staining of some pyramidal cells in sectors CA1 and CA2 show differences in the amount of phosphorylated tau, not only in different types of neurons, but also in different parts of the cell. The immunoreactivity of oligodendrocytes and the absence of the reaction in astrocytes reflect differences in tau phosphorylation in glial cells. Marked immunoreactivity in 13 dogs but minimal reaction in brains of three other dogs appears to reflect interindividual differences, which are associated presumably with genetic background. Shrinkage of neurons, tortuosity of mossy fibers, accumulation of phosphorylated tau in the nucleoplasm, and deformation of the nuclei of neurons and oligodendrocytes suggest that excessive phosphorylation at the mAb Tau-1 site is associated with neuronal and oligodendrocyte degeneration and, possibly, cell death.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9748620     DOI: 10.1016/s0006-8993(98)00542-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Differential changes in phosphorylation of tau at PHF-1 and 12E8 epitopes during brain ischemia and reperfusion in gerbils.

Authors:  W Gordon-Krajcer; E Kozniewska; J W Lazarewicz; H Ksiezak-Reding
Journal:  Neurochem Res       Date:  2006-12-27       Impact factor: 3.996

2.  Assessment of nutritional interventions for modification of age-associated cognitive decline using a canine model of human aging.

Authors:  Joseph A Araujo; Christa M Studzinski; Elizabeth Head; Carl W Cotman; Norton W Milgram
Journal:  Age (Dordr)       Date:  2005-05-02

Review 3.  Oxidative Stress and Protein Quality Control Systems in the Aged Canine Brain as a Model for Human Neurodegenerative Disorders.

Authors:  Mariarita Romanucci; Leonardo Della Salda
Journal:  Oxid Med Cell Longev       Date:  2015-05-11       Impact factor: 6.543

Review 4.  Prevention approaches in a preclinical canine model of Alzheimer's disease: benefits and challenges.

Authors:  Paulina R Davis; Elizabeth Head
Journal:  Front Pharmacol       Date:  2014-03-21       Impact factor: 5.810

5.  Natural non-trasgenic animal models for research in Alzheimer's disease.

Authors:  Manuel Sarasa; Pedro Pesini
Journal:  Curr Alzheimer Res       Date:  2009-04       Impact factor: 3.498

6.  Effect of Phosphorylated Tau on Cortical Pyramidal Neuron Morphology during Hibernation.

Authors:  Mamen Regalado-Reyes; Ruth Benavides-Piccione; Isabel Fernaud-Espinosa; Javier DeFelipe; Gonzalo León-Espinosa
Journal:  Cereb Cortex Commun       Date:  2020-05-21

7.  Lack of human-like extracellular sortilin neuropathology in transgenic Alzheimer's disease model mice and macaques.

Authors:  Feng-Qin Zhou; Juan Jiang; Chelsea M Griffith; Peter R Patrylo; Huaibin Cai; Yaping Chu; Xiao-Xin Yan
Journal:  Alzheimers Res Ther       Date:  2018-04-24       Impact factor: 6.982

8.  Cross species application of quantitative neuropathology assays developed for clinical Alzheimer's disease samples.

Authors:  Silvan R Urfer; Caitlin S Latimer; Warren Ladiges; C Dirk Keene; Sarah Benbow; Benjamin Harrison; Daniel E L Promislow; Matt Kaeberlein; Brian C Kraemer; Adrienne Wang; Franco Guscetti; Martin Darvas
Journal:  Pathobiol Aging Age Relat Dis       Date:  2019-09-03

9.  Distribution of tau hyperphosphorylation in canine dementia resembles early Alzheimer's disease and other tauopathies.

Authors:  Ajantha Abey; Danielle Davies; Claire Goldsbury; Michael Buckland; Michael Valenzuela; Thomas Duncan
Journal:  Brain Pathol       Date:  2020-09-10       Impact factor: 6.508

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.